ResearcherUniversity of OxfordNo recent work listed

Victoria Y. Strauss

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5172-512X; OpenAlex author ID A5032769641. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper

Papers 2

Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for lo… Co-author DOI 10.1186/s12885-019-5307-z ↗
A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol. Co-author DOI 10.1186/s12885-016-2765-4 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ganesh Radhakrishna · 2 shared papers, 2016–2019 · strength 0.13
- Paper Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with hi… DOI 10.1186/s12885-019-5307-z ↗
- Paper A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPA… DOI 10.1186/s12885-016-2765-4 ↗
M. Hawkins · 2 shared papers, 2016–2019 · strength 0.13
- Paper Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with hi… DOI 10.1186/s12885-019-5307-z ↗
- Paper A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPA… DOI 10.1186/s12885-016-2765-4 ↗
Somnath Mukherjee · 2 shared papers, 2016–2019 · strength 0.13
- Paper Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with hi… DOI 10.1186/s12885-019-5307-z ↗
- Paper A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPA… DOI 10.1186/s12885-016-2765-4 ↗
Tim Maughan · 1 shared paper, 2019 · strength 0.08
- Paper Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with hi… DOI 10.1186/s12885-019-5307-z ↗
Chris N Hurt · 1 shared paper, 2019 · strength 0.08
- Paper Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with hi… DOI 10.1186/s12885-019-5307-z ↗
Pippa G. Corrie · 1 shared paper, 2019 · strength 0.08
- Paper Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with hi… DOI 10.1186/s12885-019-5307-z ↗
Eric E. O’Neill · 1 shared paper, 2019 · strength 0.08
- Paper Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with hi… DOI 10.1186/s12885-019-5307-z ↗
Derek B. Grose · 1 shared paper, 2016 · strength 0.05
- Paper A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPA… DOI 10.1186/s12885-016-2765-4 ↗
D. Holyoake · 1 shared paper, 2016 · strength 0.05
- Paper A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPA… DOI 10.1186/s12885-016-2765-4 ↗
Emmanouil Fokas · 1 shared paper, 2016 · strength 0.05
- Paper A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPA… DOI 10.1186/s12885-016-2765-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.